Epstein Secrets

Trump "really did deserve, in my opinion, to be reelected. And he may yet be reelected when we count every vote." The New York Times (11/15, Fuchs, Delkic, Cameron, 18.61M) says the response from Trump and Administration officials come "as a growing number of top Republicans urged...Trump on Sunday to

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

Trump "really did deserve, in my opinion, to be reelected. And he may yet be reelected when we count every vote." The New York Times (11/15, Fuchs, Delkic, Cameron, 18.61M) says the response from Trump and Administration officials come "as a growing number of top Republicans urged...Trump on Sunday to

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

Trump "really did deserve, in my opinion, to be reelected. And he may yet be reelected when we count every vote." The New York Times (11/15, Fuchs, Delkic, Cameron, 18.61M) says the response from Trump and Administration officials come "as a growing number of top Republicans urged...Trump on Sunday to

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying